Rationale and evidence for the incorporation of heparin into the diclofenac epolamine medicated plaster

References

• Graham DJ. COX-2 inhibitors, other NSAIDs, and cardiovascular risk: the seduction of common sense. JAMA. 2006;296(13):1653–1656.
   PubMed Web of Science ®Google Scholar
• Ong CK, Lirk P, Tan CH, et al. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res. 2007;5(1):19–34.
   PubMedGoogle Scholar
• Costantini R, De Nicola P, Bianco F, et al. Tumor vs non-tumor origin of occult and obscure gastrointestinal bleeding requiring hospitalization. Tumori. 2007;93(5):461–466.
   PubMed Web of Science ®Google Scholar
• Garcia Rodriguez LA, Hernandez-Diaz S. The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res. 2001;3(2):98–101.
   PubMedGoogle Scholar
• McCarberg BH, Argoff CE. Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury. Int J Clin Pract. 2010;64(11):1546–1553.
   PubMed Web of Science ®Google Scholar
• Rainsford KD. Anti-inflammatory drugs in the 21st century. Subcell Biochem. 2007;42:3–27.
   PubMedGoogle Scholar
• Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999;340(24):1888–1899.
   PubMed Web of Science ®Google Scholar
• Derry S, Conaghan P, Da Silva JA, et al. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2016;4:CD007400.
   PubMed Web of Science ®Google Scholar
• Derry S, Wiffen PJ, Kalso EA, et al. Topical analgesics for acute and chronic pain in adults – an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;5:CD008609.
   PubMed Web of Science ®Google Scholar
• Tse S, Powell KD, Maclennan SJ, et al. Skin permeability and pharmacokinetics of diclofenac epolamine administered by dermal patch in Yorkshire-Landrace pigs. J Pain Res 2012;5:401–408.
   PubMedGoogle Scholar
• Derry S, Wiffen P, Moore A. Topical nonsteroidal anti-inflammatory drugs for acute musculoskeletal pain. JAMA. 2016;315(8):813–814.
   PubMed Web of Science ®Google Scholar
• Zeng C, Wei J, Persson MSM, et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br J Sports Med. 2018;52(10):642–650.
   PubMed Web of Science ®Google Scholar
• Altman RD, Barthel HR. Topical therapies for osteoarthritis. Drugs. 2011;71(10):1259–1279.
   PubMed Web of Science ®Google Scholar
• Petersen B, Rovati S. Diclofenac epolamine (Flector) patch: evidence for topical activity. Clin Drug Investig. 2009;29(1):1–9.
   PubMed Web of Science ®Google Scholar
• Roth SH. Coming to terms with nonsteroidal anti-inflammatory drug gastropathy. Drugs. 2012;72(7):873–879.
   PubMed Web of Science ®Google Scholar
• Schwartz JI, Dallob AL, Larson PJ, et al. Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjects. J Clin Pharmacol. 2008;48(6):745–754.
   PubMed Web of Science ®Google Scholar
• Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010;26(7):1715–1731.
   PubMed Web of Science ®Google Scholar
• Brogden RN, Heel RC, Pakes GE, et al. Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs. 1980;20(1):24–48.
   PubMed Web of Science ®Google Scholar
• Rainsford KD, Kean WF, Ehrlich GE. Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine. Curr Med Res Opin. 2008;24(10):2967–2992.
   PubMed Web of Science ®Google Scholar
• Flector patch prescribing information. Pfizer Inc, New York 10017.
   Google Scholar
• Lionberger DR, Joussellin E, Yanchick J, et al. Pooled analysis of clinical trial data evaluating the safety and effectiveness of diclofenac epolamine topical patch 1.3% for the treatment of acute ankle sprain. Open Access J Sports Med. 2011;2:75–84.
   PubMedGoogle Scholar
• Kuehl K, Carr W, Yanchick J, et al. Analgesic efficacy and safety of the diclofenac epolamine topical patch 1.3% (DETP) in minor soft tissue injury. Int J Sports Med. 2011;32(8):635–643.
   PubMed Web of Science ®Google Scholar
• Gimbel J, Jacobs D, Pixton G, et al. Effectiveness and safety of diclofenac epolamine topical patch 1.3% for the treatment of acute pain due to back strain: an open-label, uncontrolled study. Phys Sportsmed. 2011;39(1):11–18.
   PubMed Web of Science ®Google Scholar
• Brewer AR, Pierchala LA, Yanchick JK, et al. Gastrointestinal tolerability of diclofenac epolamine topical patch 1.3%: a pooled analysis of 14 clinical studies. Postgrad Med. 2011;123(4):168–176.
   PubMed Web of Science ®Google Scholar
• Lionberger DR, Lanzarotti A, Pierchala L, et al. Analgesic efficacy and safety of diclofenac epolamine topical patch (Flector patch) by location of injury in trials of acute pain: a pooled analysis of five trials. J Appl Res. 2010;10(3):97–107.
   Google Scholar
• Lionberger DR, Brennan MJ. Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch. J Pain Res 2010;3:223–233.
   PubMedGoogle Scholar
• Rusca A, Mautone G, Sun S, et al. Comparison of plasma pharmacokinetics of FLECTOR Patch (diclofenac epolamine topical patch) and oral Voltaren (diclofenac sodium enteric coated tablets) in healthy volunteers [Abstract no. 279]. J Pain. 2008;9(4 Suppl 1):45.
   PubMedGoogle Scholar
• Brunner M, Davies D, Martin W, et al. A new topical formulation enhances relative diclofenac bioavailability in healthy male subjects. Br J Clin Pharmacol. 2011;71(6):852–859.
   PubMed Web of Science ®Google Scholar
• Vecchio C, Frisinghelli A. Topically applied heparins for the treatment of vascular disorders: a comprehensive review. Clin Drug Investig. 2008;28(10):603–614.
   PubMed Web of Science ®Google Scholar
• Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA. 1999;96(13):7563–7568.
   PubMed Web of Science ®Google Scholar
• Brühlmann P, Michel BA. Topical diclofenac patch in patients with knee osteoarthritis: a randomized, double-blind, controlled clinical trial. Clin Exp Rheumatol. 2003;21(2):193–198.
   PubMed Web of Science ®Google Scholar
• Brühlmann P, de Vathaire F, Dreiser RL, et al. Short-term treatment with topical diclofenac epolamine plaster in patients with symptomatic knee osteoarthritis: pooled analysis of two randomised clinical studies. Curr Med Res Opin. 2006;22(12):2429–2438.
   PubMed Web of Science ®Google Scholar
• Rosenthal M, Bahous I. A controlled clinical study on the new topical dosage form of DHEP plasters in patients suffering from localized inflammatory diseases. Drugs Exp Clin Res. 1993;19(3):99–105.
   PubMedGoogle Scholar
• Galeazzi M, Marcolongo R. A placebo-controlled study of the efficacy and tolerability of a nonsteroidal anti-inflammatory drug, DHEP plaster, in inflammatory peri- and extra-articular rheumatological diseases. Drugs Exp Clin Res. 1993;19(3):107–115.
   PubMedGoogle Scholar
• Galer BS, Rowbotham M, Perander J, et al. Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. J Pain Symptom Manage. 2000;19(4):287–294.
   Web of Science ®Google Scholar
• Jenoure P, Segesser B, Luhti U, et al. A trial with diclofenac HEP plaster as topical treatment in minor sport injuries. Drugs Exp Clin Res. 1993;19(3):125–131.
   PubMedGoogle Scholar
• Spacca G, Cacchio A, Forgacs A, et al. Analgesic efficacy of a lecithin-vehiculated diclofenac epolamine gel in shoulder periarthritis and lateral epicondylitis: a placebo-controlled, multicenter, randomized, double-blind clinical trial. Drugs Exp Clin Res. 2005;31(4):147–154.
   PubMedGoogle Scholar
• Fioravanti A, Cicero MR, Nerucci F, et al. Double-blind controlled clinical study of the efficacy and tolerability of diclofenac-N-(2-hydroxyethyl)-pyrrolidine lecithin gel compared with diclofenac-N-(2-hydroxyethyl)-pyrrolidine gel in patients with peri and extraarticular inflammatory diseases. Drugs Exp Clin Res. 1999;25(5):235–240.
   PubMedGoogle Scholar
• Mahler P, Mahler F, Duruz H, et al. Double-blind, randomized, controlled study on the efficacy and safety of a novel diclofenac epolamine gel formulated with lecithin for the treatment of sprains, strains and contusions. Drugs Exp Clin Res. 2003;29(1):45–52.
   PubMedGoogle Scholar
• European Pharmacopoeia 9.0. Medicated plasters; 884:2017.
   Google Scholar
• Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin’s barrier function. Pharm Sci Technolo Today. 2000;3(9):318–326.
   PubMedGoogle Scholar
• IBSA Institut Biochimique SA Lugano Switzerland. Data on file. Study CRO-PK-02-92: safety evaluation of a new transdermal plaster containing DHEP and heparin sodium. 2003.
   Google Scholar
• IBSA Institut Biochimique SA Lugano Switzerland. Data on file. Study CRO-PK-12-272: diclofenac PK profile after standardised exercise, plaster occlusion and moderate heat, as compared with normal (rest) conditions, and evaluation of DHEP and heparin residual content in DHEP plus plaster after 24-h application. 2013.
   Google Scholar
• IBSA Institut Biochimique SA Lugano Switzerland. Data on file. Study CRO-PK-98-13: BA/BE study of a new topical formulation of DHEP plaster containing heparin vs. the marketed formulation Flector EP Tissugel in male and female healthy volunteers. 1998.
   Google Scholar
• Assandri A, Canali S, Giachetti C. Local tolerability and pharmacokinetic profile of a new transdermal delivery system, diclofenac hydroxyethylpyrrolidine plaster. Drugs Exp Clin Res. 1993;19(3):89–95.
   PubMedGoogle Scholar
• Affaitati G, Fabrizio A, Frangione V, et al. Effects of topical diclofenac plus heparin (DHEP + H plaster) on somatic pain sensitivity in healthy subjects with a latent algogenic condition of the lower limb. Pain Pract. 2015;15(1):58–67.
   PubMed Web of Science ®Google Scholar
• IBSA Institut Biochimique SA Lugano Switzerland. Data on file. DRT-18.125.275b: Flector–heparin patch vs Flector patch: comparison of diclofenac epolamine permeation through Epiderm MatTek membrane.
   Google Scholar
• Costantino C, Kwarecki J, Samokhin AV, et al. Diclofenac epolamine plus heparin plaster versus diclofenac epolamine plaster in mild to moderate ankle sprain: a randomized, double-blind, parallel-group, placebo-controlled, multicentre, phase III trial. Clin Drug Investig. 2011;31(1):15–26.
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Kopačka P, Gugliotta B, et al. Efficacy and tolerability of DHEP-heparin plaster in reducing pain in mild-to-moderate muscle contusions: a double-blind, randomized trial. Curr Med Res Opin. 2012;28(8):1313–1321.
   PubMed Web of Science ®Google Scholar
• Coudreuse JM, de Vathaire F. Effect of a plaster containing DHEP and heparin in acute ankle sprains with oedema: a randomized, double-blind, placebo-controlled, clinical study. Curr Med Res Opin. 2010;26(9):2221–2228.
   PubMed Web of Science ®Google Scholar
• Klainguti A, Forgacs A, Berkes I, et al. A plaster containing DHEP and heparin for mild to moderate contusions and sprains with haematoma: a double-blind randomized study. Curr Med Res Opin. 2010;26(9):2243–51.
   PubMed Web of Science ®Google Scholar
• IBSA Institut Biochimique SA Lugano Switzerland. Data on file. Study EU01.2002: DHEP/Heparin Tissugel: study on the skin irritation and sensitization potential (‘human repeated insult patch test’ – RIPT). 2003.
   Google Scholar
• IBSA Institut Biochimique SA Lugano Switzerland. Data on file. Study 13FCDN-FHp03: skin irritation and sensitization evaluation of Flector Plus patch: a phase I, ‘repeated insult patch test’ (RIPT) investigation to support the safety and tolerability of the medicated plaster (patch) formulation, in human healthy volunteers. 2003.
   Google Scholar
• Campbell J, Dunn T. Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains. J Accid Emerg Med. 1994;11(3):178–182.
   PubMedGoogle Scholar
• Dreiser RL. Topical antirheumatic drug therapy: current practice and future trends. Eur J Rheumatol Inflamm. 1994;14(4):3–8.
   PubMedGoogle Scholar
• Mazières B, Rouanet S, Velicy J, et al. Topical ketoprofen patch (100 mg) for the treatment of ankle sprain: a randomized, double-blind, placebo-controlled study. Am J Sports Med. 2005;33(4):515–523.
   PubMed Web of Science ®Google Scholar
• Mueller EA, Kirch W, Reiter S. Extent and time course of pain intensity upon treatment with a topical diclofenac sodium patch versus placebo in acute traumatic injury based on a validated end point: post hoc analysis of a randomized placebo-controlled trial. Expert Opin Pharmacother. 2010;11(4):493–498.
   PubMed Web of Science ®Google Scholar
• Russell AL. Piroxicam 0.5% topical gel compared to placebo in the treatment of acute soft tissue injuries: a double-blind study comparing efficacy and safety. Clin Invest Med. 1991;14(1):35–43.
   PubMed Web of Science ®Google Scholar